MUMBAI, India, July 26, 2024 /PRNewswire/ — InfoComm India, India’s foremost professional audiovisual (Pro AV) exhibition, is set to return to Mumbai from 3-5 September 2024 at the Jio World Convention Centre (JWCC). This year, InfoComm India 2024 expands beyond Pavilions 1 to 3 at JWCC, incorporating Jasmine Hall (at Level 3) for an even […]
Category Archives: Pr Newswire
SINGAPORE, July 27, 2024 /PRNewswire/ — Chenghe Acquisition II Co. (the “Company“) today announced that, commencing on July 29, 2024, holders of the units (the “Units“) sold in the Company’s initial public offering may elect to separately trade the Company’s Class A Ordinary Shares (the “Shares“) and warrants (the “Warrants“) included in the Units. The […]
PALO ALTO, Calif., July 27, 2024 /PRNewswire/ — Mega Matrix Corp. (“MPU” or the “Company”) (NYSE American: MPU), today announced that FlexTV, its short drama streaming platform, surged into No.8. in the App Store Entertainment Apps (Free Apps, Japan) as of July 26, 2024. FlexTV continues to excel in the Asian market! Following its 2nd […]
XINING, China, July 27, 2024 /PRNewswire/ — vivo today held the 2024 vivo Imaging Conference in Xining, China, where it showcased vivo’s latest advancements in imaging technologies. The company presented its progressive strategies surrounding three new trends in mobile imaging: imaging security, 3D imaging/XR and health imaging. In addition, the results of the VISION+ Mobile PhotoAwards […]
The positive CHMP opinion is based on results from the Phase II PHAROS trial,[1] which demonstrated an objective response rate (ORR) of 75% in treatment-naïve patients and 46% in previously treated patients. The safety profile is consistent with that observed in the approved metastatic melanoma indication[1] The European Commission decision for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) is expected […]
Pr Newswire
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million
26
Jul
Jul
Scienture, Inc., a private branded and specialty pharmaceutical company, entered into a business combination with TRxADE Health Inc., in an all-stock transaction valued at $103 million. TAMPA, FL and COMMACK, NY, July 26, 2024 (GLOBE NEWSWIRE) — TRxADE HEALTH, INC. (“TRxADE”) (Nasdaq: MEDS) and Scienture, Inc. (“Scienture”) today announced the closing of TRxADE’s business combination with Scienture […]
26
Jul
Jul
PITTSBURGH, July 26, 2024 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its second quarter 2024 financial results on Monday, August 5, 2024, prior to the open of U.S. markets. The Company’s management will also host a conference call and webcast at 8:30 am ET […]
26
Jul
Jul
PITTSBURGH, July 26, 2024 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that it has entered into a definitive agreement for the exercise of certain existing warrants to purchase an aggregate of 958,117 shares of its common stock having a current exercise price of $14.00 […]
26
Jul
Jul
CHARLOTTE, N.C., July 26, 2024 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease and the parent company of geneType™, has conducted an operations review and announces that it intends to transition to a capital light operations model – which […]
Pr Newswire
GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis
26
Jul
Jul
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 26, 2024 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency’s […]